Table 3 Genes that were significantly upregulated or downregulated between study day 1 and 14 (global p value for the pathway ≤ 0.05).
Pathway | Global p-value | Number of up- or downregulated genes | Total number of genes in the pathway |
|---|---|---|---|
Cancer pathways | 0.00002 | 23 | 327 |
Glycolysis/Gluconeogenesis | 0.00031 | 8 | 66 |
Phospholipase | 0.00227 | 5 | 38 |
Salvage pathways of pyrimidine deoxyribonucleotides | 0.00641 | 2 | 5 |
Dolichyl-diphosphooligosaccharide biosynthesis | 0.01704 | 2 | 8 |
Uracil degradation II (reductive) | 0.01704 | 2 | 8 |
Thymine degradation | 0.01704 | 2 | 8 |
Methylthiopropionate biosynthesis | 0.02600 | 1 | 1 |
Pentose phosphate pathway | 0.02647 | 2 | 10 |
MAPK signaling pathway | 0.03237 | 12 | 257 |
N-Glycan biosynthesis | 0.03827 | 4 | 49 |
NAD salvage pathway II | 0.04358 | 2 | 13 |